Bausch Health Companies (BHC) Share-based Compensation (2009 - 2026)
Bausch Health Companies' (BHC) quarterly Share-based Compensation came in at $54.0 million in Q2 2026, up 17.39% year-over-year from $46.0 million in Q2 2025, and up 3.85% quarter-over-quarter from $52.0 million in Q1 2026.
Analysis
Bausch Health Companies (BHC) Share-based Compensation (2009 - 2026) Analysis & Trends
Bausch Health Companies has disclosed Share-based Compensation across 18 years of filings, most recently posting $54.0 million for Q2 2026.
- In Q2 2026, Share-based Compensation rose 17.39% year-over-year to $54.0 million; the TTM figure through Jun 2026 stood at $233.0 million (up 37.06% YoY), while the FY2025 annual figure was $216.0 million, up 44.0% from the prior year.
- Share-based Compensation came in at $54.0 million for Q2 2026 at Bausch Health Companies, up from $52.0 million in the prior quarter.
- In the past five years, Share-based Compensation ranged from a high of $84.0 million in Q4 2025 to a low of $26.0 million in Q2 2022.
- Average Share-based Compensation over 5 years is $40.6 million, with a median of $37.0 million recorded in 2024.
- Year-over-year, Share-based Compensation decreased 21.95% in 2022 and soared 95.35% in 2025.
- Over 5 years, Share-based Compensation stood at $35.0 million in 2022, then decreased by 17.14% to $29.0 million in 2023, then surged by 48.28% to $43.0 million in 2024, then jumped by 95.35% to $84.0 million in 2025, then sank by 35.71% to $54.0 million in 2026.
- Per Business Quant data, the three most recent Share-based Compensation figures were $54.0 million in Q2 2026, $52.0 million in Q1 2026, and $84.0 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.17 Bn | 38.51 Bn | 2.15 Bn | 40.00 Mn |
| 2 | Viatris | 18.99 Bn | 18.10 Bn | 1.46 Bn | 30.40 Mn |
| 3 | Dr Reddys Laboratories | 9.74 Bn | 9.56 Bn | 396.53 Mn | 1.02 Mn |
| 4 | Amneal Pharmaceuticals | 5.41 Bn | 5.29 Bn | 334.51 Mn | 176,000.00 |
| 5 | Bausch Health Companies | 2.29 Bn | 451.38 Mn | 2.10 Bn | 54.00 Mn |
| 6 | Alvotech | 1.53 Bn | 1.39 Bn | 2.56 Mn | 2.92 Mn |
| 7 | Ani Pharmaceuticals | 1.49 Bn | 1.13 Bn | 165.89 Mn | 11.41 Mn |
| 8 | Amphastar Pharmaceuticals | 1.03 Bn | 736.38 Mn | 93.47 Mn | 29.30 Mn |
| 9 | Fennec Pharmaceuticals | 393.29 Mn | 352.05 Mn | 17.15 Mn | 7.04 Mn |
| 10 | RedHill Biopharma | 172.65 Mn | 172.65 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 54.00 Mn |
| Mar 31, 2026 | 52.00 Mn |
| Dec 31, 2025 | 84.00 Mn |
| Sep 30, 2025 | 43.00 Mn |
| Jun 30, 2025 | 46.00 Mn |
| Mar 31, 2025 | 43.00 Mn |
| Dec 31, 2024 | 43.00 Mn |
| Sep 30, 2024 | 38.00 Mn |
| Jun 30, 2024 | 36.00 Mn |
| Mar 31, 2024 | 33.00 Mn |
| Dec 31, 2023 | 29.00 Mn |
| Sep 30, 2023 | 29.00 Mn |
| Jun 30, 2023 | 33.00 Mn |
| Mar 31, 2023 | 41.00 Mn |
| Dec 31, 2022 | 35.00 Mn |
| Sep 30, 2022 | 33.00 Mn |
| Jun 30, 2022 | 26.00 Mn |
| Mar 31, 2022 | 32.00 Mn |
| Dec 31, 2021 | 33.00 Mn |
| Sep 30, 2021 | 33.00 Mn |